These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 154393

  • 1. The immunobiology of acne. A polyvalent proprionibacteria vaccine.
    Goldman L, Michael JG, Riebel S.
    Cutis; 1979 Feb; 23(2):181-4. PubMed ID: 154393
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans.
    Karvonen SL, Räsänen L, Cunliffe WJ, Holland KT, Karvonen J, Reunala T.
    Dermatology; 1994 Feb; 189(4):344-9. PubMed ID: 7873817
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris.
    Liu PF, Hsieh YD, Lin YC, Two A, Shu CW, Huang CM.
    Curr Drug Metab; 2015 Feb; 16(4):245-54. PubMed ID: 26264195
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of skin changes in acne using Propionibacterium antigens in the form of an oral vaccine].
    Kasprowicz A, Kłosiński A, Heczko PB.
    Med Dosw Mikrobiol; 1986 Feb; 38(2):73-8. PubMed ID: 2942740
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes.
    Keshari S, Kumar M, Balasubramaniam A, Chang TW, Tong Y, Huang CM.
    Expert Rev Vaccines; 2019 May; 18(5):433-437. PubMed ID: 30920859
    [Abstract] [Full Text] [Related]

  • 11. Acne vaccines: therapeutic option for the treatment of acne vulgaris?
    Kim J.
    J Invest Dermatol; 2008 Oct; 128(10):2353-4. PubMed ID: 18787542
    [Abstract] [Full Text] [Related]

  • 12. Acne from an immunological perspective.
    Puhvel SM.
    Cutis; 1976 Mar; 17(3):502-6. PubMed ID: 138543
    [Abstract] [Full Text] [Related]

  • 13. Lymphocyte transformation in subjects with nodulo cystic acne.
    Puhvel SM, Amirian D, Weintraub J, Reisner RM.
    Br J Dermatol; 1977 Aug; 97(2):205-11. PubMed ID: 143951
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Levels of antibody to Staphylococcus epidermidis in patients with acne vulgaris.
    Puhvel SM, Warnick MA, Sternberg TH.
    Arch Dermatol; 1965 Jul; 92(1):88-90. PubMed ID: 11850964
    [Abstract] [Full Text] [Related]

  • 18. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.
    Webster GF, Leyden JJ, Norman ME, Nilsson UR.
    Infect Immun; 1978 Nov; 22(2):523-9. PubMed ID: 153333
    [Abstract] [Full Text] [Related]

  • 19. Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris.
    Mouser PE, Baker BS, Seaton ED, Chu AC.
    J Invest Dermatol; 2003 Nov; 121(5):1226-8. PubMed ID: 14708633
    [No Abstract] [Full Text] [Related]

  • 20. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S, Del Rosso JQ, Bhambri A.
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.